Solution NMR studies of the Aβ(1-40) and Aβ(1-42) peptides establish that the met35 oxidation state affects the mechanism of amyloid formation

被引:485
作者
Hou, LM
Shao, HY
Zhang, YB
Li, H
Menon, NK
Neuhaus, EB
Brewer, JM
Byeon, IJL
Ray, DG
Vitek, MP
Iwashita, T
Makula, RA
Przybyla, AB
Zagorski, MG [1 ]
机构
[1] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA
[2] Univ Georgia, Dept Biochem, Athens, GA 30602 USA
[3] Ohio State Univ, Dept Chem, Chem Instrumentat Ctr, Columbus, OH 43210 USA
[4] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27710 USA
[5] Suntory Inst Bioorgan Res, Osaka 618, Japan
关键词
D O I
10.1021/ja036813f
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The pathogenesis of Alzheimer's disease is characterized by the aggregation and fibrillation of the 40-residue Abeta(1-40) and 42-residue Abeta(1-42) peptides into amyloid plaques. The structural changes associated with the conversion of monomeric Abeta peptide building blocks into multimeric fibrillar beta-strand aggregates remain unknown. Recently, we established that oxidation of the methionine-35 side chain to the sulfoxide (Met35(red) --> Met35(ox)) significantly impedes the rate of aggregation and fibrillation of the Abeta peptide. To explore this effect at greater resolution, we carefully compared the H-1, N-15, and C-13 NMR chemical shifts of four Abeta peptides that had the Met35 reduced or oxidized (Abeta(1- 40)Met35(red), Abeta(1-40)Met35(ox), Abeta(1-42)Met35(red), and Abeta(1-42)Met35(ox)). With the use of a special disaggregation protocol, the highly aggregation prone Abeta pepticles could be studied at higher, millimolar concentrations (as required by NMR) in aqueous solution at neutral pH, remaining largely monomeric at 5 degreesC as determined by sedimentation equilibrium studies. The NOE, amide-NH temperature coefficients, and chemical shift indices of the (1)Halpha, (13)Calpha, and (13)Cbeta established that the four peptides are largely random, extended chain structures, with the Met35(ox) reducing the propensity for beta-strand structure at two hydrophobic regions (Leu17-Ala21 and Ile31-Val36), and turn- or bendlike structures at Asp7-Glu11 and Phe20-Ser26. Additional NMR studies monitoring changes that occur during aging at 37 degreesC established that, along with a gradual loss of signal/noise, the Met35(ox) significantly hindered upfield chemical shift movements of the 2H NMR signals for the His6, His13, and His14 side chains. Taken together, the present NMR studies demonstrate that the Met35(red) - Met35(ox) conversion prevents aggregation by reducing both hydrophobic and electrostatic association and that the Abeta(1-40)Met35(ox), Abeta(1-40)Met35(ox), Abeta(1-42)Met35(red), and Abeta(1-42)Met35(ox) peptides may associate differently, through specific, sharp changes in structure during the initial stages of aggregation.
引用
收藏
页码:1992 / 2005
页数:14
相关论文
共 80 条
  • [51] A mathematical model of the kinetics of β-amyloid fibril growth from the denatured state
    Pallitto, MM
    Murphy, RM
    [J]. BIOPHYSICAL JOURNAL, 2001, 81 (03) : 1805 - 1822
  • [52] Recognition sequence design for peptidyl modulators of β-amyloid aggregation and toxicity
    Pallitto, MM
    Ghanta, J
    Heinzelman, P
    Kiessling, LL
    Murphy, RM
    [J]. BIOCHEMISTRY, 1999, 38 (12) : 3570 - 3578
  • [53] Oxidation of methionine 35 attenuates formation of amyloid β-peptide 1-40 oligomers
    Palmblad, M
    Westlind-Danielsson, A
    Bergquist, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) : 19506 - 19510
  • [54] A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR
    Petkova, AT
    Ishii, Y
    Balbach, JJ
    Antzutkin, ON
    Leapman, RD
    Delaglio, F
    Tycko, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (26) : 16742 - 16747
  • [55] NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, Aβ(1-40)ox and Aβ(1-42)ox
    Riek, R
    Güntert, P
    Döbeli, H
    Wipf, B
    Wüthrich, K
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (22): : 5930 - 5936
  • [56] Amyloid fibrillogenesis: themes and variations
    Rochet, JC
    Lansbury, PT
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2000, 10 (01) : 60 - 68
  • [57] Morphology and toxicity of A beta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease
    Roher, AE
    Chaney, MO
    Kuo, YM
    Webster, SD
    Stine, WB
    Haverkamp, LJ
    Woods, AS
    Cotter, RJ
    Tuohy, JM
    Krafft, GA
    Bonnell, BS
    Emmerling, MR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) : 20631 - 20635
  • [58] FIBRILLOGENESIS OF SYNTHETIC AMYLOID-BETA PEPTIDES IS DEPENDENT ON THEIR INITIAL SECONDARY STRUCTURE
    SATO, C
    CASTANO, EM
    KUMAR, RA
    BEAVIS, RC
    FRANGIONE, B
    [J]. NEUROSCIENCE LETTERS, 1995, 200 (02) : 105 - 108
  • [59] Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients
    Sattler, M
    Schleucher, J
    Griesinger, C
    [J]. PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 1999, 34 (02) : 93 - 158
  • [60] Redox processes of methionine relevant to β-amyloid oxidation and Alzheimer's disease
    Schöneich, C
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 397 (02) : 370 - 376